FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084005 [Registered on: 03/04/2025] Trial Registered Prospectively
Last Modified On: 27/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To evaluate the combined effect of Neem and Goosberry powder internally and Cassia occidentalis root powder externally in Psoriasis 
Scientific Title of Study   An open label single arm clinical study to evaluate the combined effect of Arishta Amalaki choorna and Kasamada moola lepa in Kitibha [Psoriasis] 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anbumalar R 
Designation  PG Scholar 
Affiliation  Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital  
Address  Department of kayachikitsa Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM road Thanniruhalla Hassan 573201

Hassan
KARNATAKA
573201
India 
Phone  9361251383  
Fax    
Email  anburamsen@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anbumalar R 
Designation  PG Scholar 
Affiliation  Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital  
Address  Department of kayachikitsa Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM road Thanniruhalla Hassan 573201

Hassan
KARNATAKA
573201
India 
Phone  9361251383  
Fax    
Email  anburamsen@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Lakshmiprasad L Jadhav  
Designation  Professor 
Affiliation  Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital  
Address  Department of kayachikitsa Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM road Thanniruhalla Hassan 573201

Hassan
KARNATAKA
573201
India 
Phone  9886614116  
Fax    
Email  drjadhav@sdmcahhassan.org  
 
Source of Monetary or Material Support  
Shri Dharmasthala Manjunatheshwara College of Ayurveda andd Hospital BM road Thanniruhalla, hassan 573201 
 
Primary Sponsor  
Name  SDM College of Ayurveda and Hospital 
Address  Shri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM road Thanniruhalla, hassan 573201 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
SDM College of Ayurveda and Hospital BM road Thanniruhalla hassan   Shri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital BM road Thanniruhalla, hassan 573201 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anbumalar R  Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan   Department of kayachikitsa Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital BM road Thanniruhalla Hassan 573201
Hassan
KARNATAKA 
9361251383

anburamsen@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRI DHARMASHTALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL , HASSAN  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: KITIBAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: ARISHTA AMALAKI CHOORNA , Reference: Bhaishajya ratnavaali , Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: HONEY), Additional Information: -
(2) Medicine Name: KASAMARDA MOOLA CHOORNA, Reference: Bhaishajya ratnavaali, Route: Topical, Dosage Form: Churna/ Powder, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: external application along with kanji.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Less than 1 year of chronicity
2.Subbjeccts willing to participate in study and ready to sign informed consent form 
 
ExclusionCriteria 
Details  1.uncontrolled diabetes mellitus (HBA1C more than 8mg/dl)
2.pregnant and lactating women
3.subjects with impaired cardiac, renal and hepatic functions 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessment will be based on the presence of symptoms of kitibha, i.e.Syaava varna,
Kinaka sparsha parushata,
kandu,
rukshata,
 
0th day. 16th day and 31st day 
 
Secondary Outcome  
Outcome  TimePoints 
Psoriasis Area Severity Index Score  0th day. 16th day and 31st day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   20/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study title is An Open Label Single Arm Clinical Study to Evaluate the Combined Effect of Arishta Amalaki choorna and Kasamarda moola lepa in Kitibha kushta (Psoriasis) which involves a total of 30 participants in the study, which includes age from 18 years to 60 years and less than 1 yea of chronicity and study exclude uncontrolled diabetic mellitus, pregnant and lactating women, Assessment will be done on 0th, 16th, 31st day after treatment and resulys of the following study will be analysed and calculated by using SPSS and other suitable statistical software.  
Close